Company Filing History:
1 out of 75 
1 out of 1 
1 out of 5 Years Active: 2017
Title: Rui Wang-Sattler: Innovator in Diabetes Research
Introduction
Rui Wang-Sattler is a prominent inventor based in Munich, Germany. He has made significant contributions to the field of diabetes research, particularly in identifying biomarkers for type 2 diabetes mellitus. His innovative work has the potential to impact the way diabetes is diagnosed and treated.
Latest Patents
Rui Wang-Sattler holds a patent for a method of identifying a predisposition for developing type 2 diabetes mellitus. This method involves assessing the amount of specific metabolites in a sample obtained from a subject. The invention highlights the importance of certain metabolites, such as glycine and acetylcarnitine C2, in predicting the risk of developing diabetes. Additionally, the patent includes methods for identifying compounds that can prevent diabetes and selecting appropriate therapies.
Career Highlights
Throughout his career, Rui Wang-Sattler has worked with esteemed organizations, including the Helmholtz Zentrum München and the Deutsche Diabetes-Forschungsgesellschaft. His research has focused on understanding the metabolic changes associated with diabetes, contributing to advancements in the field.
Collaborations
Rui has collaborated with notable colleagues, including Wolfgang Rathmann and Christian Herder. These partnerships have enhanced his research efforts and expanded the impact of his work in diabetes research.
Conclusion
Rui Wang-Sattler is a key figure in the innovation of diabetes diagnostics and prevention. His patent and research efforts are paving the way for new approaches to managing type 2 diabetes mellitus.